Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DexCom
DXCM
5
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 38.740
- 0.0000.00%
Close Mar 31 16:00 ET
- 38.660
- -0.080-0.21%
Pre 08:19 ET
78.74BMarket Cap24.11P/E (TTM)
38.840High37.880Low5.36MVolume38.110Open38.740Pre Close205.55MTurnover0.27%Turnover Ratio24.11P/E (Static)2.03BShares44.37652wk High4.46P/B76.18BFloat Cap31.37152wk Low1.52Dividend TTM1.97BShs Float44.376Historical High3.93%Div YieldTTM2.48%Amplitude6.306Historical Low38.364Avg Price1Lot Size
About GlaxoSmithKline Company
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Company Profile
SymbolGSK
Company NameGlaxoSmithKline
Listing DateDec 27, 2000
CEOMs. Emma N. Walmsley
MarketNYSE
Employees68629
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends12-31
Address79 New Oxford Street
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeWC1A 1DG
Phone44-20-8047-5000
Websitehttp://www.gsk.com
Company Executives
- Name
- Position
- Salary
- Dame Emma N. Waley
- Executive Director,Chief Executive Officer
- 10.56M
- Julie Brown
- Executive Director,Chief Financial Officer
- 4.17M
- Sir Jonathan Richard Symonds CBE
- Non-Executive Director,Chairman
- 781.00K
- Wendy Becker
- Non-Executive Director
- 157.00K
- Elizabeth McKee Anderson
- Non-Executive Director
- 206.00K
- Dr. Vishal Sikka
- Non-Executive Director
- 172.00K
- Dr. Jesse Goodman, M.D.,M.P.H.
- Non-Executive Director
- 228.00K
- Dr. Jeannie Lee
- Non-Executive Director
- 166.00K
- Dr. Harry C Dietz
- Non-Executive Director
- 275.00K
- Dr. Hal V Barron
- Non-Executive Director
- 462.00K
- Dr. Anne Beal
- Non-Executive Director
- 255.00K
- Charles A. Bancroft
- Non-Executive Director,Senior Independent Director
- 333.00K
- . Victoria Anne Whyte
- Company Secretary
- --
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now